Prevention effect of rare ginsenosides against stress-hormone induced MTOC amplification

Oncotarget. 2016 Jun 7;7(23):35144-58. doi: 10.18632/oncotarget.9059.

Abstract

Stress has been suggested as one of important cause of human cancer without molecular biological evidence. Thus, we test the effect of stress-related hormones on cell viability and mitotic fidelity. Similarly to estrogen, stress hormone cortisol and its relative cortisone increase microtubule organizing center (MTOC) number through elevated expression of γ-tubulin and provide the Taxol resistance to human cancer cell lines. However, these effects are achieved by glucocorticoid hormone receptor (GR) but not by estrogen receptor (ER). Since ginsenosides possess steroid-like structure, we hypothesized that it would block the stress or estrogen-induced MTOC amplification and Taxol resistance. Among tested chemicals, rare ginsenoside, CSH1 (Rg6) shows obvious effect on inhibition of MTOC amplification, γ-tubulin induction and Taxol resistance. Comparing to Fulvestant (FST), ER-α specific inhibitor, this chemical can block the cortisol/cortisone-induced MTOC deregulation as well as ER-α signaling. Our results suggest that stress hormone induced tumorigenesis would be achieved by MTOC amplification, and CSH1 would be useful for prevention of stress-hormone or steroid hormone-induced chromosomal instability.

Keywords: MTOC; cancer prevention; stress hormone.

MeSH terms

  • Cell Line, Tumor
  • Cortisone / pharmacology*
  • Ginsenosides / pharmacology*
  • Humans
  • Hydrocortisone / pharmacology*
  • Microtubule-Organizing Center / drug effects*
  • Paclitaxel / pharmacology
  • Stress, Psychological / complications*
  • Stress, Psychological / metabolism
  • Stress, Psychological / pathology

Substances

  • Ginsenosides
  • Paclitaxel
  • Cortisone
  • Hydrocortisone